Publication
LC-MS/MS methodology for simultaneous determination of patulin and citrinin in urine and plasma applied to a pilot study in colorectal cancer patients
| dc.contributor.author | Ouhib, Salma | |
| dc.contributor.author | Vidal, Arnau | |
| dc.contributor.author | Martins, Carla | |
| dc.contributor.author | Gali, Ridha | |
| dc.contributor.author | Hedhili, Abderrazzeki | |
| dc.contributor.author | De Saeger, Sarah | |
| dc.contributor.author | De Boevre, Marthe | |
| dc.date.accessioned | 2020-04-27T18:33:09Z | |
| dc.date.available | 2020-04-27T18:33:09Z | |
| dc.date.issued | 2019-11-27 | |
| dc.description.abstract | Biomarker-driven research has been proposed as a successful method to assess the exposure of individuals to xenobiotics, including mycotoxins, through estimation of their metabolites in biological fluids. A methodology to determine patulin (PAT) and citrinin (CIT) in human urine and plasma using liquid chromatography coupled to tandem mass spectrometry was developed and validated in the present study. Selectivity/specificity, linearity, limit of detection and quantification, apparent recovery, intraday- and interday-precision and measurement uncertainty were investigated for validation purposes. Finally, the method was used to analyze human urine (n = 100) and plasma (n = 100) case-control samples, where 50 samples originated from colorectal cancer patients and 50 from age/sex-matched controls. This case-control study revealed that PAT was not detected in urine samples, however occurred in 25% of the analysed plasma samples with an average concentration of 11.62 ± 6.67 ng/mL in the positive samples. CIT was found in urine samples (74%) and plasma samples (36%) with average concentrations in the positive samples of 0.45 ± 0.24 ng/mL and 0.49 ± 0.2 ng/mL respectively. No statistically significant difference of PAT and CIT concentration among colorectal cancer and control patients (p > 0.05) was observed. | pt_PT |
| dc.description.abstract | Highlights: Development and validation of an LC-MS/MS method to determine patulin and citrinin in biological fluids; Patulin was detected in plasma (25%) for the first time; Citrinin was present in 74% of Tunisian urine samples; Citrinin was present in 36% of Tunisian plasma samples. | pt_PT |
| dc.description.sponsorship | The authors acknowledge the support of the Tunisian Ministry of Education and Scientific Research, the Toxicology and Environment Research Laboratory LR12SP07 (CAMUR, Tunis, Tunisia) and MYTOXSOUTH (https://mytoxsouth.org) (Ghent University and Global Minds International Thematic Network). Dr. Arnau Vidal expresses thanks to The Research Foundation Flanders(Wetenschappelijk Oderzoek- Vlaanderen, FWO) for the postdoctoral grant (12Y1719N). | pt_PT |
| dc.description.version | info:eu-repo/semantics/publishedVersion | pt_PT |
| dc.identifier.citation | Food Chem Toxicol. 2020 Feb;136:110994. doi: 10.1016/j.fct.2019.110994. Epub 2019 Nov 27 | pt_PT |
| dc.identifier.doi | https://doi.org/10.1016/j.fct.2019.110994 | pt_PT |
| dc.identifier.issn | 0278-6915 | |
| dc.identifier.uri | http://hdl.handle.net/10400.18/6533 | |
| dc.language.iso | eng | pt_PT |
| dc.peerreviewed | yes | pt_PT |
| dc.publisher | Elsevier/ Pergamon | pt_PT |
| dc.relation.publisherversion | https://www.sciencedirect.com/science/article/pii/S0278691519307847?via%3Dihub | pt_PT |
| dc.subject | LC-MS/MS | pt_PT |
| dc.subject | Mycotoxin Exposure | pt_PT |
| dc.subject | Cancer | pt_PT |
| dc.subject | Plasma | pt_PT |
| dc.subject | Urine | pt_PT |
| dc.subject | Segurança Alimentar | pt_PT |
| dc.subject | Toxicologia | pt_PT |
| dc.subject | Avaliação de Risco | pt_PT |
| dc.subject | Saúde Humana | pt_PT |
| dc.title | LC-MS/MS methodology for simultaneous determination of patulin and citrinin in urine and plasma applied to a pilot study in colorectal cancer patients | pt_PT |
| dc.type | journal article | |
| dspace.entity.type | Publication | |
| oaire.citation.startPage | 110994 | pt_PT |
| oaire.citation.title | Food and Chemical Toxicology | pt_PT |
| oaire.citation.volume | 136 | pt_PT |
| rcaap.embargofct | De acordo com política editorial da revista. | pt_PT |
| rcaap.rights | embargoedAccess | pt_PT |
| rcaap.type | article | pt_PT |
Files
Original bundle
1 - 1 of 1
No Thumbnail Available
- Name:
- LC-MSMS methodology for simultaneous determination of patulin and citrinin in urine and plasma applied to a pilot study in colorectal cancer patients.pdf
- Size:
- 308.82 KB
- Format:
- Adobe Portable Document Format
License bundle
1 - 1 of 1
No Thumbnail Available
- Name:
- license.txt
- Size:
- 1.71 KB
- Format:
- Item-specific license agreed upon to submission
- Description:
